ATE180275T1 - Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin - Google Patents

Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin

Info

Publication number: ATE180275T1
Authority: AT; Austria
Prior art keywords: epimorphine; epimorphin; base sequence; gene; active substance
Prior art date: 1991-10-16

Application number

AT92921384T

Other languages

English (en)

Inventor

Yohei Hirai

Makoto Takashina

Kyoko Takebe

Original Assignee

Biomaterial Res Inst Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-16

Filing date

1992-10-15

Publication date

1999-06-15

1992-10-15 Application filed by Biomaterial Res Inst Co Ltd filed Critical Biomaterial Res Inst Co Ltd

1999-06-15 Application granted granted Critical

1999-06-15 Publication of ATE180275T1 publication Critical patent/ATE180275T1/de

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
239000013543 active substance Substances 0.000 title abstract 2
108700038219 Syntaxin-2 Proteins 0.000 title 2
102100035936 Syntaxin-2 Human genes 0.000 title 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000002209 hydrophobic effect Effects 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108010029485 Protein Isoforms Proteins 0.000 abstract 1
102000001708 Protein Isoforms Human genes 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
238000005352 clarification Methods 0.000 abstract 1
230000002950 deficient Effects 0.000 abstract 1
230000018109 developmental process Effects 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
210000000981 epithelium Anatomy 0.000 abstract 1
208000035851 morphological anomaly Diseases 0.000 abstract 1
239000000523 sample Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
230000025934 tissue morphogenesis Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT92921384T 1991-10-16 1992-10-15 Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin ATE180275T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP29485791		1991-10-16
JP29485691		1991-10-16
JP12290692		1992-04-17
JP13569292		1992-04-30

Publications (1)

Publication Number	Publication Date
ATE180275T1 true ATE180275T1 (de)	1999-06-15

Family

ID=27470892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92921384T ATE180275T1 (de)	1991-10-16	1992-10-15	Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin

Country Status (7)

Country	Link
US (1)	US5726298A (de)
EP (1)	EP0562123B1 (de)
JP (1)	JP2849517B2 (de)
AT (1)	ATE180275T1 (de)
CA (1)	CA2098397C (de)
DE (1)	DE69229219T2 (de)
WO (1)	WO1993008213A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06293800A (ja) *	1992-10-15	1994-10-21	Bio Material Kenkyusho:Kk	新規生理活性物質エピモルフィン、それをコードする遺伝子及びエピモルフィンに対する抗体
JPH09500013A (ja) *	1993-06-01	1997-01-07	ライフ・テクノロジーズ・インコーポレイテッド	カチオン性脂質による遺伝子免疫
CA2152210C (en) *	1994-06-21	2001-09-04	Yohei Hirai	Modified epimorphin
JPH107698A (ja)	1996-04-24	1998-01-13	Sumitomo Electric Ind Ltd	エピモルフィン・アンタゴニスト
JP3903503B2 (ja) *	1996-11-18	2007-04-11	住友電気工業株式会社	可溶性ポリペプチド
JP2000060560A (ja) *	1998-08-20	2000-02-29	Sumitomo Electric Ind Ltd	偶蹄目エピモルフィン
CA2350882C (en)	1998-11-12	2011-02-22	Life Technologies Corporation	Transfection reagents
AU2001262689B2 (en) *	2000-06-05	2006-07-06	Sumitomo Electric Industries, Ltd.	Oligopeptides
US7241731B2 (en) *	2000-06-05	2007-07-10	Sumitomo Electric Industries, Ltd.	Oligopeptides for promoting hair growth
US20050008602A1 (en) *	2000-06-05	2005-01-13	Sumitomo Electric Industries, Ltd.	Oligopeptides for promoting hair growth
AU2002301607B2 (en) *	2001-11-13	2008-12-11	Sumitomo Electric Industries, Ltd.	Oligopeptides for promoting hair growth
AU2003203527A1 (en) *	2002-04-12	2003-10-30	Sumitomo Electric Industries, Ltd.	Control of the ratio of lap to lip
TW200505945A (en)	2003-05-16	2005-02-16	Sumitomo Electric Industries	Oligopeptides
JP5228246B2 (ja) *	2007-11-05	2013-07-03	国立大学法人京都大学	三次元疾患皮膚再構築物
US10195280B2 (en)	2014-07-15	2019-02-05	Life Technologies Corporation	Compositions and methods for efficient delivery of molecules to cells

1992
- 1992-10-15 AT AT92921384T patent/ATE180275T1/de active
- 1992-10-15 JP JP4301582A patent/JP2849517B2/ja not_active Expired - Fee Related
- 1992-10-15 DE DE69229219T patent/DE69229219T2/de not_active Expired - Lifetime
- 1992-10-15 EP EP92921384A patent/EP0562123B1/de not_active Expired - Lifetime
- 1992-10-15 WO PCT/JP1992/001340 patent/WO1993008213A1/ja not_active Ceased
- 1992-10-15 CA CA002098397A patent/CA2098397C/en not_active Expired - Fee Related
1996
- 1996-08-16 US US08/690,457 patent/US5726298A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0562123A4 (de)	1995-03-15
EP0562123B1 (de)	1999-05-19
CA2098397C (en)	1999-07-06
JP2849517B2 (ja)	1999-01-20
JPH0625295A (ja)	1994-02-01
EP0562123A1 (de)	1993-09-29
US5726298A (en)	1998-03-10
WO1993008213A1 (en)	1993-04-29
DE69229219D1 (de)	1999-06-24
DE69229219T2 (de)	1999-11-04
CA2098397A1 (en)	1993-04-17

Similar Documents

Publication	Publication Date	Title
DE69229219D1 (de)	1999-06-24	Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin
Kim et al.	2000	Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
Hebert et al.	1991	Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.
James	1990	Interactions between cytokines and α2-macroglobulin
DE68929256T2 (de)	2001-05-17	Humaner Rezeptor Fc(gamma)RIII
DE69523750T2 (de)	2002-08-01	Modulatoren der cytokine der tgf-beta überfamilie und verfahren zu ihrer bestimmung
US5416192A (en)	1995-05-16	Epithelins: novel cysteine-rich growth modulating proteins
HU9402823D0 (en)	1995-01-30	Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
DE68920693D1 (de)	1995-03-02	Gefriergetrocknete Zusammensetzung, die ein mit Meerrettichperoxydase markiertes Fab'-Fragment eines gegen menschliches Beta-Interferon gerichteten Antikörpers und Trehalose enthält; EIA Kit, der diese Zusammensetzung enthält.
Young III et al.	1980	Opioid receptors undergo axonal flow
FI921353A0 (fi)	1992-03-27	Inhibering av transformerande vaextfaktor b foer foerhindrande av ackumulation av extracellulaer matris.
JP2007209349A (ja)	2007-08-23	新規な神経栄養因子
Diana et al.	1999	Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus
CN109535243A (zh)	2019-03-29	人肝细胞生长因子突变体及其应用
Sweetwyne et al.	2004	Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies
ES2259458T3 (es)	2006-10-01	Persefina humana.
DE3751893D1 (de)	1996-10-10	Polypeptid und dessen Herstellung
CA2420226A1 (en)	2002-02-28	Methods for treating demyelinating diseases
Haagmans et al.	1997	Transforming growth factor beta production during rat cytomegalovirus infection.
DE69232779D1 (de)	2002-10-24	Menschlicher Rezeptor für das Follikel-stimulierendes Hormon.
Josephsen et al.	1990	The effect of a single dose of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on presecretory ameloblast differentiation in rat incisors.
Ikeda et al.	1991	Immunohistochemical distribution of simple-epithelial-type keratins and other intermediate filament proteins in the developing human pituitary gland
EP1025854A1 (de)	2000-08-09	Verwendung depletorisch oder mitogen wirkender Antikörper gegen CD3/TCR in der Immuntherapie
Keller et al.	1990	Immunohistochemical localisation of nerve growth factor in a subpopulation of chick spinal ganglion neurons
Wolf et al.	1981	Selye's Guide to Stress Research, vol 1\| Edited by Hans Selye, 368 pages, $22.50, New York, Van Nostrand Reinhold, 1980.